Cornea - ARVO

More documents

Recommendations

Info

ARVO 2013 Annual Meeting Abstracts by Scientific Section/Group - Corneadepth (Figure 2). Whole porcine eyes were placed at the device’sfocal plane. Images from the side cameras were recorded at regularintervals after the application of RF solution.Results: Sequences of images recorded at regular intervals duringand after the application of RF solution showed increasedfluorescence at increased depths within the cornea. A focal planeangle of 18.2° to the apex of the eye was found to increase theuseable depth of field of the system by a factor of over 2.5.Conclusions: An advanced riboflavin dosimetry device is presented.The KXL-II system combines the use of UVA projection via a DMDwith side cameras that monitor riboflavin fluorescence in the cornea.The camera’s tilted focal plane relaxes the constraints on the systemsdepth of field. The DMD allows for rapid alternation betweenillumination profiles intended for cross-linking treatment and slitconfigurations intended for fluorescent dosimetry. With this device itmay be possible to respond and compensate to live dosimetryreadings as riboflavin is consumed and measured at various depthswithin the cornea. Real time dosimetry measurements will play asignificant role in determining the underlying mechanisms of cornealcross-linking and assist with the development of additional riboflavinformulations.Figure 1 Schematic of slit UVA illumination projected on to theCornea.topographer [Jongsma et al. OVS; 1998]. Three tasks were set. SinceESP requires instillation of fluorescein, the optimal combination ofthe fluorescein strips and the eye physiological solution that results inthe best quality of recorded images was assessed. Further, therepeatability of the instrument in measuring artificial and real eyesurfaces was studied. Finally, the new topographer was tested inclinical settings against traditional Placido disk topographer (E300,Medmont) for a range of normal, astigmatic, and highly aberratedeyes (post corneal grafts).Results: The best results in terms of highly resolved ESP imageshave been achieved with BIO GLO sterile strips (1 mg fluoresceinsodium) with Hial eye drops (0.4 mg/ml hialuronian sodium). Forartificial surfaces, the repeatability of instrument in a dynamic case,when operator manually focused the instrument, was very high whilethe accuracy of the instrument in terms of the RMS error was lessthan 10um but depended on the instrument-surface distance. Theworking distance was estimated at +/-250um from the best focalplane. For real eyes, the coverage area was routinely greater than16mm and often reached up to 20mm diameter. Single instillation offluorescein allowed acquisition from 3 to 20 measurements (taken inless than 30 second intervals). Repeatability, evaluated withrefractive spherical component over an 8 mm corneal diameter, washigh (differences less than 0.125 D). When tested against the E300topographer, ESP showed excellent repeatability for spherical power(in an 8 mm corneal diameter) but seemed to overestimate theastigmatic component, which seemed to depend on the instrument’sworking distance. For highly aberrated eyes, in situations where E300could not perform a valid measurement, the ESP was still performingwell.Conclusions: ESP has high potential clinical utility. It couldsubstitute the currently used videokeratoscopes and provide a newdiagnostic quality in those applications in which information oncorneoscleral topography is of essence.Commercial Relationships: D Robert Iskander, Eaglet Eye (F),Eaglet Eye (I)Support: Eaglet Eye - research grantFigure 2 Schematic showing side camera’s use of Sceimpflugprinciple. Focal plane intersects with measurement zone in cornea.Commercial Relationships: Marc D. Friedman, Avedro Inc (E);David B. Usher, Avedro Inc (E); Radha Pertaub, Avedro Inc (E);David Muller, Avedro Inc (E)Program Number: 533 Poster Board Number: B0170Presentation Time: 10:30 AM - 12:15 PMThe clinical utility of the Eye Surface ProfilerD Robert Iskander. Institute of Biomedical Engineering andInstrumentation, Wroclaw University of Technology, Wroclaw,Poland.Purpose: To evaluate the effectiveness of the Eye Surface Profiler inmeasuring the topography of the anterior eye surface.Methods: Eye Surface Profiler (ESP) is a newly developed corneaand sclera topographer that can measure up to 20mm of the anteriorsurface of the eye. It is an evolution of a wide field height eyeProgram Number: 534 Poster Board Number: B0171Presentation Time: 10:30 AM - 12:15 PMSubclinical Keratoconus Detection Based On PentacamScheimpflug Tomography IndicesPablo R. Ruisenor Vazquez 1, 2 , Marianella Delrivo 2 , FernandoFuentes Bonthoux 1, 2 , Tomás Pfortner 2 , Pablo Chiaradia 1 , JeremiasG. Galletti 1, 2 . 1 Ophthalmology Division, Hospital de Clínicas,University of Buenos Aires, Buenos Aires, Argentina; 2 ECOS(Clinical Ocular Studies) Laboratoy, Buenos Aires, Argentina.Purpose: To evaluate the diagnostic performance of corneal indicesprovided by the Pentacam tomograph for detecting subclinicalkeratoconus.Methods: Observational case series of 136 eyes from 136 healthysubjects in group 1 and 42 topographically-unremarkable eyes from42 keratoconic patients in group 2, evaluated with cornealtopography, aberrometry, and Scheimpflug tomography for Belin-Ambrosio D indices. For data analysis, Student's t test was used tocompare means and receiver operating characteristic (ROC) curveswere used to analyze the diagnostic performance of D indices forkeratoconus detection. The statistical significance criteria used was p
ARVO 2013 Annual Meeting Abstracts by Scientific Section/Group - Cornea(0.24 ± 0.07 vs 0.66 ± 0.35 µm, p
Page 2 and 3: ARVO 2013 Annual Meeting Abstracts
Page 10: ARVO 2013 Annual Meeting Abstracts
Page 70 and 71:
ARVO 2013 Annual Meeting Abstracts
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
Page 272 and 273:
Page 274 and 275:
Page 276 and 277:
Page 278 and 279:
Page 280 and 281:
Page 282 and 283:
Page 284 and 285:
Page 286 and 287:
Page 288 and 289:
Page 290 and 291:
Page 292 and 293:
Page 294 and 295:
Page 296 and 297:
Page 298 and 299:
Page 300 and 301:
Page 302 and 303:
Page 304 and 305:
Page 306 and 307:
Page 308 and 309:
Page 310 and 311:
Page 312 and 313:
Page 314 and 315:
Page 316 and 317:
Page 318 and 319:
Page 320 and 321:
Page 322 and 323:
Page 324 and 325:
Page 326 and 327:
Page 328 and 329:
Page 330 and 331:
Page 332 and 333:
Page 334 and 335:
Page 336 and 337:
Page 338 and 339:
Page 340 and 341:
Page 342 and 343:
Page 344 and 345:
Page 346 and 347:
Page 348 and 349:
Page 350 and 351:
Page 352 and 353:
Page 354 and 355:
Page 356 and 357:
Page 358 and 359:
Page 360 and 361:
Page 362 and 363:
Page 364 and 365:
Page 366 and 367:
Page 368 and 369:
Page 370 and 371:
Page 372 and 373:
Page 374 and 375:
Page 376 and 377:
Page 378 and 379:
Page 380 and 381:
Page 382 and 383:
show all

Cornea - ARVO

Create successful ePaper yourself

Delete template?

Save as template?